Adimmune (TPE:4142) E10: NT$ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4142 Adimmune Corp TPE:4142
59 GF Score
Price NT$17.80
GF Value NT$22.77
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Adimmune E10?

Adimmune TPE:4142 +0.28% 59 E10 is NT$ as of Jun. 2026. GuruFocus rates TPE:4142 with a GF Score™ of 59/100 and a GF Value™ of NT$22.77 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Adimmune's adjusted earnings per share data for the three months ended in Jun. 2026 was NT$-0.380. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$ for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average E10 Growth Rate was 17.30% per year. During the past 5 years, the average E10 Growth Rate was 14.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Adimmune was 17.30% per year. The lowest was 11.40% per year. And the median was 14.60% per year.

As of today (2026-09-20), Adimmune's current stock price is NT$17.80. Adimmune's E10 for the quarter that ended in Jun. 2026 was NT$. Adimmune's Shiller PE Ratio of today is .


Adimmune  (TPE:4142) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Adimmune E10 Related Terms


Adimmune E10 Historical Data

* Premium members only.

The historical data trend for Adimmune's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune E10 Chart

Adimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Adimmune Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

TPE:4142 vs VRTX, REGN, MRNA: E10 Comparison

For the Biotechnology subindustry, Adimmune's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adimmune Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adimmune's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Adimmune's Shiller PE Ratio falls into.


TPE:4142
59GF Score
Adimmune Corp TPE:4142
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adimmune E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Adimmune's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.3801/333.9520*333.9520
=-0.380

Current CPI (Jun. 2026) = 333.9520.

Adimmune Quarterly Data

per share eps CPI Adj_EPS
201609 -0.522 241.428 -0.722
201612 -0.864 241.432 -1.195
201703 -0.798 243.801 -1.092
201706 -0.598 244.955 -0.815
201709 -0.456 246.819 -0.617
201712 -1.225 246.524 -1.659
201803 -0.722 249.554 -0.966
201806 -0.313 251.989 -0.415
201809 -0.024 252.439 -0.032
201812 -1.403 251.233 -1.864
201903 -0.788 254.202 -1.035
201906 -0.618 256.143 -0.805
201909 0.305 256.759 0.397
201912 -0.060 256.974 -0.078
202003 -0.045 258.115 -0.059
202006 -0.350 257.797 -0.453
202009 0.376 260.280 0.482
202012 2.888 260.474 3.703
202103 -0.582 264.877 -0.733
202106 -0.379 271.696 -0.466
202109 0.375 274.310 0.456
202112 0.687 278.802 0.822
202203 -0.546 287.504 -0.634
202206 0.106 296.311 0.119
202209 0.983 296.808 1.106
202212 0.143 296.797 0.161
202303 -0.591 301.836 -0.654
202306 -0.571 305.109 -0.625
202309 0.626 307.789 0.679
202312 -0.982 306.746 -1.069
202403 -0.437 312.332 -0.467
202406 -0.650 314.175 -0.690
202409 0.625 315.301 0.662
202412 -0.115 315.605 -0.121
202503 -0.530 319.799 -0.553
202506 -0.519 322.561 -0.537
202509 -0.043 324.800 -0.045
202512 0.523 324.054 0.539
202603 -0.440 330.213 -0.445
202606 -0.380 333.952 -0.380

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$ mean?
Adimmune (TPE:4142) has a E10 of NT$ as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Adimmune and its competitors.
Is Adimmune's E10 too high?
Adimmune's current E10 is NT$. Overall, Adimmune has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Adimmune's E10 compare to VRTX and REGN?
Adimmune's E10 of NT$ can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Adimmune and its competitors. Adimmune's current E10 is NT$. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adimmune stock overvalued right now?
Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.77, compared to a current price of NT$17.80 — trading 21.8% below its estimated fair value. The current E10 is NT$. Adimmune's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Adimmune (TPE:4142), the current E10 is NT$ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$17.80 is trading 21.8% below its estimated GF Value™ of NT$22.77. GuruFocus considers Adimmune to be Modestly Undervalued.

Key valuation signals for TPE:4142:

  • E10: NT$
  • GF Value™: NT$22.77 vs. price of NT$17.80 (21.8% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
59GF Score

Get the complete analysis for TPE:4142

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.80
Price
NT$22.77
GF Value